Studies indicate that rising incidence of hematological diseases represents one of the major global health threats. JOINN’s pharmacology and efficacy research team has extensive preclinical experience with therapeutics for hematological diseases. We have built a comprehensive suite of disease models for hematological disorders, including thrombosis, bleeding, anemia, thrombocytopenia, myeloproliferative neoplasms, hemolytic anemia and hematopoietic injury.
| Disease | Model | Species |
| Coagulation Disorders | Arterial thrombosis, deep vein thrombosis, hemophilia models | Mice, Rats, Rabbits, Dogs |
| Anemia | Renal anemia, chemotherapy induced anemia, aplastic anemia | Rats/Mice, NHPs |
